1. Burdick, D.; Liang, J.Pyrimidine Kinase Inhibitors. WO 2007/120339 A1, December 15,2006.
2. Inhibition of both focal adhesion kinase and insulin-like growth factor-I receptor kinase suppresses glioma proliferation in vitro and in vivo
3. Identification of NVP-TAE684, a potent, selective, and efficacious inhibitor of NPM-ALK
4. cImbach, P.; Kawahar, E.; Konishi, K.; Matsuura, N.; Miyake, T.; Ohmori, O.; Roesel, J.; Teno, N.; Umemura, I.Pyrimidine Derivatives. WO 2006/021454 A2, August 27,2004.
5. dGarcia-Echeverria, C.; Kanazawa, T.; Kawahara, E.; Masuya, K.; Matsuura, N.; Miyake, T.; Ohmori, O.; Umemura, I.; Steensma, R.; Chopiuk, G.; Jiang, J.; Wan, Y.; Ding, Q.; Zhang, Q.; Gray, N.; Karanewsky, D.2,4-Pyrimidinediamines Useful in the Treatment of Neoplastic Diseases, Inflammatory and Immune System Disorders. WO 2005/016894 A1, September 24,2003.